Ciappenelli to replace Healey at Sepracor

Share this article:
Sepracor appointed Rob Ciappenelli to replace Tim Healey as head of its CNS portfolio, which includes the company's Lunesta franchise, according to reports and sources close to the company. Sepracor declined to confirm the appointment, saying it was against corporate policy.   

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.